Apex Biotechnology Corp.
Research Apex Biotechnology Corp. (1733.TW) on Bullrun: market cap TWD 3.01B, P/E 15.9, dividend yield 4.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1733.TW
- ExchangeTW
- CountryTaiwan
- SectorHealthcare
- IndustryMedical Devices
- CurrencyTWD
- Market capTWD 3.01B
- P/E15.9
- Dividend yield4.6%
- Financial periodQ2 2026
- RevenueTWD 470.65M
- Net incomeTWD 36.78M
- Free cash flowTWD 147.15M
- Gross margin33.6%
Valuation Snapshot
latest market cap is TWD 3.01B; P/E is 15.9; dividend yield is 4.6%.
Peer valuation comparison
Latest P/E is 15.93x versus a Healthcare sector median of 21.8x (26.9% below).
Latest dividend yield is 4.55% versus a Healthcare sector median of 2.4% (89.6% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 3.01B | 15.9 | 4.3% | 1.3 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.3 TWD, yield 4.6%.
About Apex Biotechnology Corp.
Apex Biotechnology Corp. researches, develops, manufactures, and sells home care medical devices by using biosensor technology worldwide. It offers blood glucose, uric acid, hemoglobin, cholesterol, lactate, HbA1C, and ketone monitoring systems, as well as coagulation and multifunctional self-testing systems. The company also provides pesticide residue check systems; and care management and tele-health services. The company was incorporated in 1997 and is headquartered in Hsinchu City, Taiwan.
ETFs that hold Apex Biotechnology Corp.
US-listed ETFs
Apex Biotechnology Corp. is held by 7 US-listed ETFs, going by the latest portfolios they filed with the SEC, most traded first:
| ETF | Weight | Fee |
|---|---|---|
| Dimensional Emerging Core Equity Market ETF (DFAE) | <0.01% | 0.29% |
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
| Dimensional World ex U.S. Core Equity 2 ETF (DFAX) | <0.01% | 0.28% |
| Dimensional Emerging Markets Value ETF (DFEV) | <0.01% | 0.43% |
| State Street SPDR S&P Emerging Markets Small Cap ETF (EWX) | 0.01% | 0.65% |
| Dimensional Emerging Markets Sustainability Core 1 ETF (DFSE) | <0.01% | 0.41% |
| Avantis Emerging Markets Small Cap Equity ETF (AVEE) | <0.01% | 0.42% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Apex Biotechnology Corp.'s market cap?
Apex Biotechnology Corp.'s market capitalization is TWD 3.01B.
What is Apex Biotechnology Corp.'s P/E ratio?
Apex Biotechnology Corp.'s price-to-earnings (P/E) ratio is 15.9.
Does Apex Biotechnology Corp. pay a dividend?
Apex Biotechnology Corp. has a dividend yield of 4.6%.
What does Apex Biotechnology Corp. do?
Apex Biotechnology Corp. researches, develops, manufactures, and sells home care medical devices by using biosensor technology worldwide. It offers blood glucose, uric acid, hemoglobin, cholesterol, lactate, HbA1C, and ketone monitoring systems, as well as coagulation and multifunctional self-testing systems. The company also provides pesticide residue check systems; and care management and tele-health services. The company was incorporated in 1997 and is headquartered in Hsinchu City, Taiwan.